HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

15-hydroxy-5,8,11,13-eicosatetraenoic acid

potent & selective inhibitor of platelet lipoxygenase; RN given refers to cpd without isomeric designation
Also Known As:
15-HETE; 15-hydroxy-5,8,11,13-eicosatetraenoic acid, (S-(E,Z,Z,Z))-isomer
Networked: 150 relevant articles (3 outcomes, 18 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Zhu, Daling: 29 articles (01/2018 - 05/2003)
2. Zhang, Lei: 12 articles (08/2014 - 02/2009)
3. Ma, Jun: 7 articles (09/2013 - 01/2010)
4. Li, Qian: 6 articles (06/2016 - 05/2006)
5. Shen, Tingting: 6 articles (01/2016 - 10/2012)
6. Ma, Cui: 6 articles (09/2013 - 11/2010)
7. Guo, Lei: 6 articles (11/2010 - 06/2008)
8. Wang, Shuang: 5 articles (01/2016 - 02/2010)
9. Qiu, Zhaoping: 5 articles (01/2012 - 02/2009)
10. Li, Yumei: 4 articles (01/2016 - 02/2009)

Related Diseases

1. Chronic Renal Insufficiency
2. Reperfusion Injury
3. Convalescence
4. Brain Ischemia (Cerebral Ischemia)
5. Hypoxia (Hypoxemia)

Related Drugs and Biologics

1. Eicosanoids
2. Glucose (Dextrose)
3. Aligeron (AS 2)
4. Interleukin-6 (Interleukin 6)
5. Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
6. 13-hydroxy-9,11-octadecadienoic acid
7. 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
8. Arachidonic Acid (Vitamin F)
9. Leukotriene B4
10. Acids

Related Therapies and Procedures

1. Renal Dialysis (Hemodialysis)
2. Therapeutics
3. Tocolysis
4. Prostatectomy (Retropubic Prostatectomy)
5. Aftercare (After-Treatment)